ROCKVILLE, Md.—The U.S. Pharmacopeial Convention (USP) and the Chinese Pharmacopoeia Commission (ChP) signed a memorandum of understanding to identify areas of possible collaboration that can improve the quality of the pharmaceutical and food supplies in the United States and China. The move renews a prior agreement that had been in place since 2005 between USP, a private standard-setting organization, and ChP, which holds legal responsibility in China for creating and revising national medicine standards.
Roger L. Williams, USP executive vice president and CEO, stated: “This agreement represents our combined commitment to improving patient care and advancing the public health in the United States and China through rigorous quality standards for medicines.”
Areas of potential collaboration include:
Develop processes to update existing monograph standards and add new monographs;
Consider new approaches to allow review, testing and audits of manufacturers of ingredients for import and export between the countries;
Expedite the translations of the USP and ChP compendia into the other languages; and
Hold a joint scientific symposium biannually and hold senior management meetings annually.
Email this article
Add a comment
Printer version
Order reprints
RSS Feed
Bookmark article